Advertisment

Indian Journal of Nephrology About us |  Subscription |  e-Alerts  | Feedback | Login   
  Print this page Email this page   Small font sizeDefault font sizeIncrease font size
 Home | Current Issue | Archives| Ahead of print | Search |Instructions |  Editorial Board  

Users Online:819

Official publication of the Indian Society of Nephrology
  Search
 
  
 ~  Similar in PUBMED
 ~  Search Pubmed for
 ~  Search in Google Scholar for
 ~Related articles
 ~  Article in PDF (1,778 KB)
 ~  Citation Manager
 ~  Access Statistics
 ~  Reader Comments
 ~  Email Alert *
 ~  Add to My List *
* Registration required (free)  

 
   Abstract
  Introduction
  Methods
  Result
  Discussion
  Conclusion
   References
   Article Figures
   Article Tables

 Article Access Statistics
    Viewed1643    
    Printed29    
    Emailed0    
    PDF Downloaded48    
    Comments [Add]    

Recommend this journal

 


 
  Table of Contents  
ORIGINAL ARTICLE
Year : 2021  |  Volume : 31  |  Issue : 3  |  Page : 218-224
 

Effects of rosmarinic acid on methotrexate-induced nephrotoxicity and hepatotoxicity in wistar rats


1 Department of Anatomy, School of Medicine, Dezful University of Medical Sciences, Dezful, Iran
2 Student Research Committee, Dezful University of Medical Sciences, Dezful, Iran
3 Department of Anatomical Sciences, School of Medicine, Student Research Committee, Shiraz University of Medical Sciences, Shiraz, Iran
4 Department of Clinical Biochemistry, Faculty of Medicine, Lorestan University of Medical Sciences, Khorramabad, Iran
5 Department of Clinical Biochemistry, Faculty of Medicine, Lorestan University of Medical Sciences; Razi Herbal Researches Center, Lorestan University of Medical Sciences, Khorramabad, Iran

Date of Submission10-Jan-2020
Date of Acceptance17-Jul-2020
Date of Web Publication27-Jan-2021

Correspondence Address:
Prof. Hassan Ahmadvand
Department of Biochemistry, Faculty of Medicine, Lorestan University of Medical Sciences, Khorramabad
Iran
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/ijn.IJN_14_20

Rights and Permissions

  Abstract 


Introduction: Methotrexate (MTX), used in the treatment of cancerous patients, causes toxicity in the different organs of the body. This study of rosmarinic acid (RA) is as an antioxidant on nephrotoxicity and hepatotoxicity induced by MTX. Methods: Rats (n = 32) were divided into four groups: sham; MTX; 100 mg\kg RA + MTX; 200 mg/kg RA + MTX. The amount of MTX was 20 mg/kg. 24 hours after injection of the last dose of MTX, the blood samples and kidneys and liver of rats were studied. The aminotransferase (AST), alanine aminotransferase (ALT), alkaline phosphatase (ALP), urea, serum creatinine were assessed. Tissue antioxidant enzymes and malondialdehyde (MDA) levels were measured. The liver and kidney tissues were histopathologically examined. Results: MTX significantly increased the urea, creatinine, ALT, AST, ALP levels, and renal MDA and significantly decreased renal catalase (CAT), hepatic glutathione (GSH), and hepatic CAT activity. MTX induced necrosis, leukocyte infiltration, eosinophilic casts, glomerular damage in kidney tissue and necrosis, degeneration and cellular vacuolization in liver tissues. RA at 100 mg/kg caused a significant decrease in ALT and AST and at two doses significantly decreased urea, renal MDA, and liver MDA. RA at 200 mg/kg significantly increased the renal CAT and liver GSH. RA in two doses significantly decreased necrosis and Leukocyte infiltration. RA caused a significant decrease in degeneration and cellular vacuolization in liver tissues. Conclusions: RA with its antioxidant and anti-inflammatory characteristics decreased the MTX induced nephrotoxicity and hepatotoxicity.


Keywords: Hepatotoxicity, methotrexate, nephrotoxicity, rat, rosmarinic acid


How to cite this article:
Jafaripour L, Naserzadeh R, Alizamani E, Javad Mashhadi SM, Moghadam ER, Nouryazdan N, Ahmadvand H. Effects of rosmarinic acid on methotrexate-induced nephrotoxicity and hepatotoxicity in wistar rats. Indian J Nephrol 2021;31:218-24

How to cite this URL:
Jafaripour L, Naserzadeh R, Alizamani E, Javad Mashhadi SM, Moghadam ER, Nouryazdan N, Ahmadvand H. Effects of rosmarinic acid on methotrexate-induced nephrotoxicity and hepatotoxicity in wistar rats. Indian J Nephrol [serial online] 2021 [cited 2021 Jul 27];31:218-24. Available from: https://www.indianjnephrol.org/text.asp?2021/31/3/218/307998





  Introduction Top


Methotrexate (MTX) is a drug widely used in the treatment of inflammatory diseases such as psoriasis, rheumatoid arthritis, treatment of leukemia, and other cancers. This drug not only destroys cancerous cells but also causes injury in the normal tissues of the body.[1],[2],[3] High levels of MTX causes injuries in the vital organs such as liver and kidney with prevalence of hepatic fibrosis at 50% and hepatic cirrhosis at 26%. As MTX is excreted by renal tubules, the sediment of MTX and its metabolites also causes renal function disorders.[4],[5] MTX produces reactive oxygen species (ROS) and reduces the efficiency of antioxidant enzymes, induces apoptosis, and destroys both cancerous and healthy cells by producing ROS and decreases the efficiency of antioxidant enzymes.[3],[4],[5],[6] Rosmarinic Acid (RA), both as strong antioxidant and phenolic compounds can be found in various plants such as Rosmarinus officinalis, Perilla frutescens (perilla), Origanum, Vulgare, Thymus vulgaris, Menthe spicata, and Ocimum basilicum.[7] Like most antioxidants, RA leads to a reduction of oxidative stress in the pathological conditions due to its antioxidant and anti-inflammatory properties.[8] Thus, the purpose of the current study was to explore the protective impact of RA on the reduction of oxidative stress and reinforcement of the antioxidant system in methotrexate-induced hepatotoxicity and nephrotoxicity.


  Methods Top


Drugs and chemicals

The methotrexate (Sigma-Aldrich, France) and rosmarinic acid (536954/USA) were bought to perform this study.

Animals

All animal experiments were carried out based on internationally accepted guidelines for the use of animals in research and were approved by the ethics committee of Dezful University of Medical Sciences, Iran (Ethical number: IR.DUMS.REC.1396.10. Approved on October 22, 2016). Wistar rats (n = 32; weighting 200–220 g) were kept in a similar condition of a temperature of 22 ± 2 and humidity of 50 ± 10% with 12 hours light/dark cycle during this procedure in the animal lab of Dezful University of Medical Sciences.

Experimental design

Rats (n = 32) were randomly divided into four groups (n = 8 for each group).

Group 1 (sham): daily they received 0.5 ml saline intraperitoneally for 3 days.

Group 2: received 20 mg/kg MTX daily intraperitoneally for 3 days.

Group 3: received 20 mg/kg MTX + 100 mg/kg rosmarinic acid.

Group 4: received 20 mg/kg MTX + 200 mg/kg rosmarinic acid.

Rosmarinic acid daily was injected by gavage as pretreatment in each of its two doses for 12 days.[9],[10] Methotrexate was injected intraperitoneally on the tenth, eleventh, and twelfth days along with rosmarinic acid. Twenty-four hours after injection of the last dose of MTX, the blood samples of anesthetized rats were taken then their livers and kidneys were separated to assess histological and biochemical parameters.

Renal and Liver functional tests

The blood samples of animals were centrifugated with 3000 rpm for 10 minutes. After separation of their plasma, alkaline phosphatase (ALP), aminotransferase (AST), aspartate, alanine aminotransferase (ALT), urea, serum creatinine of samples were evaluated with Pars Azmon commercial kits and autoanalyzer.

Oxidative stress markers

The left kidney and liver tissues were removed, homogenized, and ten-fold of phosphate-buffered saline (PBS) was added to them. The ultimate solution was centrifugated at 4°C with 12500 rpm for 15 minutes. The supernatant was used to assess glutathione (GSH) and glutathione peroxidase (GPX), catalase (CAT), and malondialdehyde (MDA). MDA levels of the kidney and liver were measured by the Buege method,[11] and their absorbance was read at 532 nm. Glutathione levels of liver and kidney were evaluated by the Ellman method. Then, their absorbance was read at 412 nm with a spectrophotometer instrument.[12] The GPX level of kidney and liver tissues was assessed by the Fielding method and the absorption of GPX was read at 470 nm.[13] The amount of renal and hepatic catalase was evaluated by the Aebi method and its absorbance was measured by spectrophotometer.[14]

Histopathological assessments

Renal and hepatic tissues were kept in 10% neutral formalin at least for 48 hours. After assessment with ethanol solutions and xylene, they were embedded in paraffin. The block was cut into 5-μm sections and stained with eosin and hematoxylin. Then, these were examined by a light microscope under 400 × magnification. Renal injuries were measured by such parameters as leukocyte infiltration, tubular necrosis, eosinophilic casts, and glomerular damage. The Caramelo method was used to evaluate leukocyte infiltration, tubular necrosis, and eosinophilic casts as follows:[15]

No damage = 0,

Mild = 1; unicellular, patchy isolated,

Moderate = 2; damage less than 25%,

Severe = 3; damage between 25 and 50%,

Very severe = 4; more than 50% damage

Glomerular damage was assessed based on the Cakir method. Glomerular alternations such as narrowness and destruction of Bowman's space and its clasp into Bowman's capsule were assessed by this method and were semi-quantitatively scored as follows:

0: none of these mentioned cases was observed, no damage,

1: less than 25% of gamers were affected,

2: between 25 and 50% of Gamers were affected,

3: more than 50% of gamers were affected[16]

In this study, liver tissue injuries were semi-quantitatively scored by assessment of parameters such as necrosis, degeneration, cellular vacuolization.

0: no damage 1: mild damage 2: moderate damage 3: severe damage.[17]

Statistical analysis

Data were analyzed using one-way ANOVA. The Tukey test was used to compare groups two by two. Statistical significance was accepted at P < 0.05 and values expressed as mean ± SEM. The statistical analysis was run by SPSS 23.0 and the Graph Pad Prism 6 used to illustrate the article graphs.


  Result Top


Effects of RA on renal function

Urea and serum creatinine index in different groups is indicated in [Figure 1]. The urea and creatinine levels in the MTX group had significantly increased compared with the sham group. Compared with the MTX group, pretreatment with RA in its two doses decreased the urea level and this reduction in 100 mg/kg group was significant (p < 0.05). RA did not decrease the serum creatinine in both receiving groups.
Figure 1: Effects of Rosmarinic acid on kidney function tests in methotrexate-induced hepatorenaltoxicity. Data were expressed mean ± SEM (n = 8). Data were analyzed by one-way ANOVA followed by Tukey's post hoc test. * Significant difference compared to MTX group (P < 0.05), # significant difference compared to Sham group (P < 0.05)

Click here to view


Effects of RA on liver function

In this study, ALP, AST, and ALT were evaluated as liver function markers. The serum level of these tests was reported by graphs in [Figure 2]. ALT, AST, and ALP levels in the MTX group significantly increased (p < 0.05). Pretreatment with RA in 100 mg/kg could significantly decrease the AST, ALT levels (p < 0.05).
Figure 2: Effects of Rosmarinic acid on liver function tests in methotrexate-induced hepatorenaltoxicity. Data were expressed mean ± SEM (n = 8). Data were analyzed by one-way ANOVA followed by Tukey's post hoc test. * Significant difference compared to MTX group (P < 0.05), # significant difference compared to Sham group (P < 0.05)

Click here to view


Effects of RA on renal oxidative stress parameter and antioxidant enzymes

The level of antioxidant enzymes and renal MDA levels are illustrated in [Table 1]. MDA, as the final product of lipid peroxidation and oxidative stress index, significantly increased in the sham group (p < 0.05). Receipt of RA in both groups significantly reduced the MDA level (p < 0.05). GSH level, and GPX and CAT activities in groups receiving MTX decreased compared with the sham group, but this decline only was significant in CAT (p < 0.05). The level of GSH and activity of all other antioxidants (CAT & GPX) in groups receiving RA as pretreatment showed an increase; except that the CAT activity in group 4 showed a significant increase (p < 0.05).
Table 1: Effects of Rosmarinic acid on lipid peroxidation and antioxidant markers of renal tissue in methotrexate-induced hepatorenal toxicity

Click here to view


Effects of RA on liver oxidative stress parameter and antioxidant markers

Liver oxidative stress markers are reported in [Table 2]. There was no significant difference in MDA level in both sham and MTX groups, but pretreatment with RA significantly decreased the liver MDA compared with the MTX group (p < 0.05). GSH level and CAT activity in the MTX group significantly declined compared with the sham group (p < 0.05). Treatment with RA only at 200 mg/kg dose significantly increased the GSH (P < 0.05).
Table 2: Effects of Rosmarinic acid on lipid peroxidation and antioxidant markers of liver tissue in methotrexate-induced hepatorenaltoxicity

Click here to view


Effect of RA on renal histopathology

The amount of tubular necrosis, leukocyte infiltration, eosinophilic casts, and glomerular damage of renal tissue is reported in [Table 3]. Receiving MTX caused renal tissue destruction; consequently, all of the above cases had significantly increased tissue destruction compared with the sham group (p < 0.05). Receipt of RA as a pretreatment could considerably decline the amount of renal tissue destruction and this was observed in all of above cases except eosinophilic casts in RA 200 mg/kg group, and the amount of glomerular damage in the group received RA 100 mg/kg did not reveal any significant decrease [Figure 3].
Table 3: Effects of Rosmarinic acid on histology of the kidney in methotrexate.induced hepatorenaltoxicity

Click here to view
Figure 3: Effect of rosmarinic acid on kidney histopathological changes in methotrexate induced nephrotoxicity model. (Stained by hematoxylin and eosin with magnified × 400). a: Sham, b: MTX, c: MTX-RA 100, d: MTX-RA 200

Click here to view


Effects of RA on liver histopathology

Liver tissue changes in groups explored in this study are illustrated in [Table 4]. The tissue parameters examined in this study are as follows: necrosis; degeneration; and cellular vacuolization. MTX significantly increased the amount of these three parameters compared with the sham group (p < 0.05). RA in its two doses could significantly decrease the amount of degeneration and cellular vacuolization compared with the MTX group (p < 0.05). Although RA decrease necrosis of liver cells, this decline was not significant [Figure 4].
Table 4: Effects of Rosmarinic acid on histology of the liver in methotrexate-induced hepatorenaltoxicity

Click here to view
Figure 4: Effect of rosmarinic acid on liver histopathological changes in methotrexate induced hepatotoxicity model. (Stained by hematoxylin and eosin with magnified × 400). a: Sham, b: MTX, c: MTX-RA 100, d: MTX-RA 200

Click here to view



  Discussion Top


The injection of 20 mg/kg MTX for 9 days caused functional disorder in both liver and kidney. According to the results of biochemical examinations, MTX caused the increase of oxidative stress and the decrease of antioxidant enzymes in liver and kidney tissues. Also, histopathological damage and lesions were found in the liver and kidney. Receiving RA as a pretreatment with two doses of 100 mg/kg and 200 mg/kg for 12 days led to improvement of liver and kidney functions, reinforcement of antioxidant system, and decrease of hepatic and renal tissue destructions. Thus, it can be concluded that RA has decreased the hepatotoxicity and nephrotoxicity induced by methotrexate. Oxidative stresses induced by MTX cause the increase of lipid peroxidation product, MDA, No level, MPO activity, and then decrease of catalase activity and glutathione level that finally lead to hepatic and renal injuries.[1],[18],[19] Our study revealed an increase in serum level of AST, ALT, ALP induced by injection of 20 kg/mg MTX for 9 days. The increase in the level of these tests indicates liver function disorder. The results of previous studies also showed that MTX leads to liver function injuries; consequently, it increases the level of its functional tests.[17],[18],[20],[21] In our study, serum urea level in the group treated with MTX has increased that it indicated the induced nephrotoxicity. The previous studies have also reported the increase of functional tests induced by injection of MTX.[17],[21] According to current studies, the use of antioxidants such as thymoquinone, diosmin, and berberine has hopefully decreased the level of renal and hepatic function tests in animals treated with MTX.[20],[17],[21] A significant decrease in urea, creatinine, AST, ALT was observed in the group treated with 100 mg/kg rosmarinic acid. RA played an important role in the decline of various disease injuries such as sepsis, hepatotoxicity induced by using acetaminophen, renal ischemia-reperfusion in an animal model.[10],[22],[23] MTX caused an increase of oxidative stress in hepatic and renal tissues; as a result, the increase of MDA level in these organs, and the decrease in the antioxidant defensive system; especially renal CAT, and hepatic GSH which significantly increased. Recent studies conducted on toxicity induced by treatment with MTX in an animal model have reported the increase of oxidative stress in different organs, and the decrease of antioxidant enzymes.[20],[17],[21],[24],[25] In some studies, berberine, diosmin, thymoquinone, and silymarin directly decrease the lesions by removing the ROS and indirectly by increasing the number of injured organ antioxidants due to their antioxidant properties.[20],[17],[21],[26] RA possibly reduced hepatotoxicity and nephrotoxicity induced by MTX by the decrease of lipid peroxidation due to its antioxidant and anti-inflammatory properties, and RA ameliorates the abnormalities of these organ.

MTX causes renal and hepatic tissue injuries by, producing oxidative stress, ROS, caspase 3, and apoptotic markers attributed to the properties of anti-cancer drug.[18],[19],[27],[28] Histopathological analysis of liver and kidney tissue showed that the use of 20 mg/kg MTX causes the increase of tubular necrosis, leukocyte infiltration, eosinophilic casts, glomerular damage in kidney tissue, and necrosis, cellular vacuolization, degeneration in liver tissue that MTX likely causes tissue necrosis, increases inflammation and edema, and leads to the mentioned tissue changes by producing ROS. Most of previous studies have also reported the histopathological renal and hepatic changes induced by use of MTX.[20],[17],[21],[27],[28] Some antioxidants decrease the tissue injuries induced by treatment with MTX via reducing oxidative conditions.[20],[17],[21],[28] In our study, RA caused the decrease of tissue inflammation, cellular necrosis, and degeneration in liver and kidney. RA prevented the formation of free radicals; therefore, the injury to DNA and its necrosis will decrease. Furthermore, RA directly decreases the inflammation and bleeding in tissues because of its anti-inflammatory activity.[22],[23] Rosmarinic acid decreased painful peripheral neuropathy that may be due to its anti-inflammatory, and anti-apoptotic properties.[29] RA had beneficial effects in on memory deficits induced by cerebral ischemia that it may be related to antioxidant, antiapoptotic activities and anti-inflammatory and synaptogenic mechanisms of RA.[30] The effect of rosmarinic acid in the bile duct ligation model indicated beneficial effects against inflammation, oxidative stress, and fibrosis. Thus, rosmarinic acid might be beneficial in treating cholestatic liver injury.[31] In addition, RA decreased TGF-β1, CTGF expression that this improves biochemical parameter and histopathological. Different mechanisms exists for liver toxicity and RA improves liver damage in the different models.[32] In Domitrovic ´et al's study, RA ameliorated acute liver toxicity by induction of the Nrf2/HO-1 pathway that it in this model RA reduced inflammation, hepatic oxidative, and apoptosis in liver.[33] RA inhibited tumor growth by suppression of inflammatory cytokines, angiogenic factors, and NF-kB p65 in the H22-xenografts model,[34] and Renal damage induced by gentamicin is ameliorated by lycopene and rosmarinic acid alone or combined.[35] Natural antioxidants such as curcumin, garlic, olive leaves, rosemary, and pomegranate prevent kidney disease and renal dysfunctions in animal models. Furthermore, these antioxidants might be beneficial for humans.[36] Thus, RA may reduce tissue injuries induced by MTX due to its anti-inflammatory and anti-apoptotic properties.


  Conclusion Top


The findings of this study show that RA in an animal model with its antioxidant and anti-inflammatory properties can play an important role in the prevention of renal and hepatic injuries induced by MTX. RA and foods which contain this compound may help in the treatment of acute kidney and liver toxicity.

Acknowledgments

We would like to appreciate the help from all the researchers at Dezful University of Medical Sciences and the research center of Razi Herbal Research Center of Lorestan University of Medical Sciences.

Financial support and sponsorship

Dezful University of Medical Sciences and the research center of Razi Herbal Research Center of Lorestan University of Medical Sciences.

Conflicts of interest

There are no conflicts of interest.



 
  References Top

1.
Morsy MA, Ibrahim SA, Amin EF, Kamel MY, Rifaai RA, Hassan MK. Curcumin ameliorates methotrexate-induced nephrotoxicity in rats. Adv Pharmacol Sci 2013;2013: 387071. doi: 10.1155/2013/387071.  Back to cited text no. 1
    
2.
Widemann BC, Adamson PC. Understanding and managing methotrexate nephrotoxicity. Oncologist 2006;11:694-703.  Back to cited text no. 2
    
3.
Sener G, Eksioglu-Demiralp E, Çetiner M, Ercan F, Yegen BÇ. β-glucan ameliorates methotrexate-induced oxidative organ injury via its antioxidant and immunomodulatory effects. Eur J Pharmacol 2006;542:170-8.  Back to cited text no. 3
    
4.
El-Sheikh AA, van den Heuvel JJ, Koenderink JB, Russel FG. Interaction of nonsteroidal anti-inflammatory drugs with multidrug resistance protein (MRP) 2/ABCC2-and MRP4/ABCC4-mediated methotrexate transport. J Pharmacol Exp Ther 2007;320:229-35.  Back to cited text no. 4
    
5.
Yeo CM, Chong VH, Earnest A, Yang WL. Prevalence and risk factors of methotrexate hepatoxicity in Asian patients with psoriasis. World J Hepatol 2013;5:275-80.  Back to cited text no. 5
    
6.
Conklin KA. Chemotherapy-associated oxidative stress: Impact on chemotherapeutic effectiveness. Integr Cancer Ther 2004;3:294-300.  Back to cited text no. 6
    
7.
Domitrovic R, Škoda M, Marchesi VV, Cvijanovic O, Pugel EP, Štefan MB. Rosmarinic acid ameliorates acute liver damage and fibrogenesis in carbon tetrachloride-intoxicated mice. Food Chem Toxicol 2013;51:370-8.  Back to cited text no. 7
    
8.
Domitrovic R, Potocnjak I, Crncevic-Orlic Ž, Škoda M. Nephroprotective activities of rosmarinic acid against cisplatin-induced kidney injury in mice. Food Chem Toxicol 2014;66:321-8.  Back to cited text no. 8
    
9.
Tavafi M, Ahmadvand H. Effect of rosmarinic acid on inhibition of gentamicin induced nephrotoxicity in rats. Tissue Cell 2011;43:392-7.  Back to cited text no. 9
    
10.
Tavafi M, Sameni HR, Tamjidipour A, Hasanvand A, Ashoory H. Antioxidant effect of rosmarinic acid against renal ischemia-reperfusion injury in rat; a histopathological study. Ann Res Antioxid 2016;1:e24.  Back to cited text no. 10
    
11.
Buege JA, Aust SD.[30] Microsomal lipid peroxidation. Methods in enzymology. 52: Elsevier; 1978. p. 302-10.  Back to cited text no. 11
    
12.
Ellman GL. Tissue sulfhydryl groups. Arch Biochem Biophys 1959;82:70-7.  Back to cited text no. 12
    
13.
Fielding JL, Hall J. A biochemical and cytochemical study of peroxidase activity in roots of Pisum sativum: II. Distribution of enzymes in relation to root development. J Exp Bot 1978;29:983-91.  Back to cited text no. 13
    
14.
Aebi H.[13] Catalase in vitro. Methods in enzymology. 105: Elsevier; 1984. p. 121-6.  Back to cited text no. 14
    
15.
Caramelo C, Espinosa G, Manzarbeitia F, Cernadas M, Pe G, Tan D, et al. Role of endothelium-related mechanisms in the pathophysiology of renal ischemia/reperfusion in normal rabbits. Circ Res 1996;79:1031-8.  Back to cited text no. 15
    
16.
Çakir T, Polat C, Bastürk A, Gül M, Aslan A, Durgut H, et al. The effect of alpha lipoic acid on rat kidneys in methotrexate induced oxidative injury. Eur Rev Med Pharmacol Sci 2015;19:2132-9.  Back to cited text no. 16
    
17.
Abdel-Daim MM, Khalifa HA, Abushouk AI, Dkhil MA, Al-Quraishy SA. Diosmin attenuates methotrexate-induced hepatic, renal, and cardiac injury: A biochemical and histopathological study in mice. Oxid Med Cell Longev 2017;2017:3281670. doi: 10.1155/2017/3281670.  Back to cited text no. 17
    
18.
Armagan I, Bayram D, Candan IA, Yigit A, Celik E, Armagan HH, et al. Effects of pentoxifylline and alpha lipoic acid on methotrexate-induced damage in liver and kidney of rats. Environ Toxicol Pharmacol 2015;39:1122-31.  Back to cited text no. 18
    
19.
Ali N, Rashid S, Nafees S, Hasan SK, Sultana S. Beneficial effects of Chrysin against Methotrexate-induced hepatotoxicity via attenuation of oxidative stress and apoptosis. Mol Cell Biochem 2014; 385:215-23.  Back to cited text no. 19
    
20.
Mehrdad S, Fatemi I, Esmaeilizadeh M, Ghaznavi H, Kalantar H, Goudarzi M. Hepatoprotective effect of berberine against methotrexate-induced liver toxicity in rats. Biomed Pharmacother 2018;97:233-9.  Back to cited text no. 20
    
21.
El-Sheikh AA, Morsy MA, Abdalla AM, Hamouda AH, Alhaider IA. Mechanisms of thymoquinone hepatorenal protection in methotrexate-induced toxicity in rats. Mediators Inflamm 2015;2015:859383. doi: 10.1155/2015/859383.  Back to cited text no. 21
    
22.
Bacanli M, Aydin S, Taner G, Göktas H, Sahin T, Basaran A, et al. Does rosmarinic acid treatment have protective role against sepsis-induced oxidative damage in Wistar Albino rats? Hum Exp Toxicol 2016;35:877-86.  Back to cited text no. 22
    
23.
Hasanein P, Sharifi M. Effects of rosmarinic acid on acetaminophen-induced hepatotoxicity in male Wistar rats. Pharm Biol 2017;55:1809-16.  Back to cited text no. 23
    
24.
Arpag H, Gül M, Aydemir Y, Atilla N, Yigitcan B, Cakir T, et al. Protective effects of alpha-lipoic acid on methotrexate-induced oxidative lung injury in rats. J Invest Surg 2018;31:107-13.  Back to cited text no. 24
    
25.
Yüncü M, Bükücü N, Bayat N, Sencar L, Tarakçioglu M. The effect of vitamin E and L-carnitine against methotrexate-induced injury in rat testis. Turk J Med Sci 2015;45:517-25.  Back to cited text no. 25
    
26.
Mehmet KF, Sefa K, Cuneyt C, Cihan G, Adoum BA, Ilhami G. Therapeutic effects of silymarin and naringin on methotrexate-induced nephrotoxicity in rats: Biochemical evaluation of anti-inflammatory, antiapoptotic, and antiautophagic properties. J Food Biochem 2017;41:e12398.  Back to cited text no. 26
    
27.
Ibrahim MA, El-Sheikh AA, Khalaf HM, Abdelrahman AM. Protective effect of peroxisome proliferator activator receptor (PPAR)-α and-γ ligands against methotrexate-induced nephrotoxicity. Immunopharmacol Immunotoxicol 2014;36:130-7.  Back to cited text no. 27
    
28.
Mukherjee S, Ghosh S, Choudhury S, Adhikary A, Manna K, Dey S, et al. Pomegranate reverses methotrexate-induced oxidative stress and apoptosis in hepatocytes by modulating Nrf2-NF-γB pathways. J Nutr Biochem 2013;24:2040-50.  Back to cited text no. 28
    
29.
Rahbardar MG, Amin B, Mehri S, Mirnajafi-Zadeh SJ, Hosseinzadeh H. Rosmarinic acid attenuates development and existing pain in a rat model of neuropathic pain: An evidence of anti-oxidative and anti-inflammatory effects. Phytomedicine 2018;40:59-67.  Back to cited text no. 29
    
30.
Fonteles AA, de Souza CM, de Sousa Neves JC, Menezes APF, Santos do Carmo MR, Fernandes FDP, et al. Rosmarinic acid prevents against memory deficits in ischemic mice. Behav Brain Res 2016;297:91-103.  Back to cited text no. 30
    
31.
Lin SY, Wang YY, Chen WY, Liao SL, Chou ST, Yang CP, et al. Hepatoprotective activities of rosmarinic acid against extrahepatic cholestasis in rats. Food Chem Toxicol 2017;108:214-23.  Back to cited text no. 31
    
32.
Elufioye TO, Habtemariam S. Hepatoprotective effects of rosmarinic acid: Insight into its mechanisms of action. Biomed Pharmacother 2019;112:108600. doi: 10.1016/j.biopha. 2019.108600.  Back to cited text no. 32
    
33.
Domitrovic R, Škoda M, Vasiljev Marchesi V, Cvijanovic O, Pernjak Pugel E, Štefan MB. Rosmarinic acid ameliorates acute liver damage and fibrogenesis in carbon tetrachloride-intoxicated mice. Food and Chem Toxicol 2013;51:370-8.  Back to cited text no. 33
    
34.
Cao W, Hu C, Wu L, Xu L, Jiang W. Rosmarinic acid inhibits inflammation and angiogenesis of hepatocellular carcinoma by suppression of NF-γB signaling in H22 tumor-bearing mice. J Pharmacol Sci 2016;132:131-7.  Back to cited text no. 34
    
35.
Bayomy NA, Elbakary RH, Ibrahim MA, Abdelaziz EZ. Effect of Lycopene and Rosmarinic acid on gentamicin induced renal cortical oxidative stress, apoptosis, and autophagy in adult male albino rat. Anat Rec 2017;300:1137-49.  Back to cited text no. 35
    
36.
Azab AE, Albasha MO, Elsayed ASI. Prevention of nephropathy by some natural sources of antioxidants. Yangtze Med 2017;1:235-66.  Back to cited text no. 36
    


    Figures

  [Figure 1], [Figure 2], [Figure 3], [Figure 4]
 
 
    Tables

  [Table 1], [Table 2], [Table 3], [Table 4]



 

Top
Print this article  Email this article
 

    

Indian Journal of Nephrology
Published by Wolters Kluwer - Medknow
Online since 20th Sept '07